EV/EBITDA
-1.64
+0.10+5.75%
Tue, 25 Feb 2025 00:11:43 GMT
Summary
- As of February 25, 2025, SGMO EV/EBITDA is -1.64, with a rise of +0.10 (+5.75%) during the most recent trading day.
- Over the past year, SGMO EV/EBITDA has increased by +0.31 (+15.90%).
- SGMO EV/EBITDA is now -556.00% below its all-time high of -0.25.
Performance
SGMO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SGMO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +5.8% | -5.8% | -5.5% |
| 1 m1 month | +14.1% | -14.0% | -13.4% |
| 3 m3 months | +46.2% | -46.3% | -44.9% |
| 6 m6 months | -74.5% | +13.4% | +20.5% |
| ytdytd | -1.2% | +1.0% | +1.0% |
| 1 y1 year | +15.9% | +7.7% | -6.4% |
| 5 y5 years | +80.0% | -74.1% | -85.4% |
SGMO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -2.06 | +20.4% | |
| 3 m | 3-month | -1.47 | -11.6% | -4.60 | +64.3% |
| 6 m | 6-month | -0.79 | -107.6% | -4.96 | +66.9% |
| 1 y | 1-year | -0.25 | -556.0% | -4.96 | +66.9% |
| 3 y | 3-year | -0.25 | -556.0% | -5.78 | +71.6% |
| 5 y | 5-year | -0.25 | -556.0% | -32.70 | +95.0% |
| alltime | all time | -0.25 | -556.0% | -310.86 | +99.5% |
Sangamo Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.64(+1.2%) |
| 2024 | -1.62(+65.3%) |
| 2023 | -0.98(-62.9%) |
| 2022 | -2.64(-54.6%) |
| 2021 | -5.82(-68.2%) |
| 2020 | -18.32(+87.3%) |
| 2019 | -9.78(-31.0%) |
| 2018 | -14.18(-43.6%) |
| 2017 | -25.13(+807.2%) |
| 2016 | -2.77(-77.8%) |
| 2015 | -12.49(-68.6%) |
| 2014 | -39.81(+21.8%) |
| 2013 | -32.69(+136.9%) |
| Date | Value |
|---|---|
| 2012 | -13.80(+266.0%) |
| 2011 | -3.77(-68.5%) |
| 2010 | -11.98(-8.0%) |
| 2009 | -13.02(+162.5%) |
| 2008 | -4.96(-77.1%) |
| 2007 | -21.67(+105.2%) |
| 2006 | -10.56(+33.7%) |
| 2005 | -7.90(-64.8%) |
| 2004 | -22.43(+69.4%) |
| 2003 | -13.24(+549.0%) |
| 2002 | -2.04(-91.0%) |
| 2001 | -22.55(-61.2%) |
| 2000 | -58.16 |
FAQ
- What is Sangamo Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Sangamo Therapeutics?
- What is SGMO EV/EBITDA year-to-date change?
- What is Sangamo Therapeutics EV/EBITDA year-on-year change?
What is Sangamo Therapeutics EV/EBITDA?
The current EV/EBITDA of SGMO is -1.64
What is the all time high EV/EBITDA for Sangamo Therapeutics?
Sangamo Therapeutics all-time high EV/EBITDA is -0.25
What is SGMO EV/EBITDA year-to-date change?
Sangamo Therapeutics EV/EBITDA has changed by -0.02 (-1.23%) since the beginning of the year
What is Sangamo Therapeutics EV/EBITDA year-on-year change?
Over the past year, SGMO EV/EBITDA has changed by +0.31 (+15.90%)